FindTrial
Sign In

Clinical application of 18F-FDG PET / CT imaging in the follow-up of DTC patients with elevated serum level of TgAb

Clinical application of 18F-FDG PET / CT imaging in the follow-up of DTC patients with elevated serum level of TgAb

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-16008560
Enrollment
Unknown
Registered
2016-05-30
Start date
2015-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Differentiated thyroid carcinoma

Interventions

Gold Standard:
Index test:

Sponsors

Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: DTC patients who have undergone thyroidectomy and subsequent 131I ablation therapy with elevated serum level of TgAb

Exclusion criteria

Exclusion criteria: 1. can not expressed or understood informed consent; 2. unable or unwilling to complete communication research

Design outcomes

Primary

MeasureTime frame
Anti-thyroglobulin antibody;—

Countries

China

Contacts

Public ContactBaoping Liu

Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University

liubp5000@sina.com+86 13673665205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026